Long-term follow up of the CLL2007FMP trial evaluating fludarabine and cyclophosphamide in combination with either rituximab or alemtuzumab in previously untreated patients with chronic lymphocytic leukemia

Saved in:
Bibliographic Details
Published inHaematologica (Roma) Vol. 103; no. 7; pp. e304 - e306
Main Authors Feugier, Pierre, Aurran, Thérèse, Mahé, Béatrice, Letestu, Remi, Nguyen-Khac, Florence, Cazin, Bruno, Tournilhac, Olivier, Maisonneuve, Hervé, Casasnovas, Olivier, Delmer, Alain, Leblond, Véronique, Royer, Bruno, Corront, Bernadette, Chevret, Sylvie, Delépine, Roselyne, Vaudaux, Sandrine, Van Den Neste, Eric, Béné, Marie-Christine, Cymbalista, Florence, Ross-Weil, Damien, Leprêtre, Stéphane
Format Journal Article
LanguageEnglish
Published Italy Ferrata Storti Foundation 01.07.2018
Subjects
Hematology
Human health and pathology
Life Sciences
Online Only
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-2
content type line 63
ObjectType-Correspondence-1
PMCID: PMC6029553
ISSN:0390-6078
1592-8721
DOI:10.3324/haematol.2017.183350